$12.21
8.53% yesterday
NYSE, Nov 25, 10:10 pm CET
ISIN
US30050B1017
Symbol
EVH
Sector
Industry

Evolent Health Inc Class A Stock price

$12.21
-11.81 49.17% 1M
-11.07 47.55% 6M
-20.82 63.03% YTD
-17.35 58.69% 1Y
-15.85 56.49% 3Y
+1.55 14.54% 5Y
-6.65 35.26% 10Y
NYSE, Closing price Mon, Nov 25 2024
+0.96 8.53%
ISIN
US30050B1017
Symbol
EVH
Sector
Industry

Key metrics

Market capitalization $1.42b
Enterprise Value $2.13b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 19.46
EV/Sales (TTM) EV/Sales 0.87
P/S ratio (TTM) P/S ratio 0.58
P/B ratio (TTM) P/B ratio 1.35
Revenue growth (TTM) Revenue growth 37.65%
Revenue (TTM) Revenue $2.46b
EBIT (operating result TTM) EBIT $10.86m
Free Cash Flow (TTM) Free Cash Flow $109.58m
Cash position $112.93m
EPS (TTM) EPS $-0.91
P/E forward negative
P/S forward 0.56
EV/Sales forward 0.83
Short interest 12.38%
Show more

Is Evolent Health Inc Class A a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

Evolent Health Inc Class A Stock Analysis

Unlock Scores for Free

Analyst Opinions

17 Analysts have issued a Evolent Health Inc Class A forecast:

16x Buy
94%
1x Hold
6%

Analyst Opinions

17 Analysts have issued a Evolent Health Inc Class A forecast:

Buy
94%
Hold
6%

Financial data from Evolent Health Inc Class A

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
2,464 2,464
38% 38%
100%
- Direct Costs 2,190 2,190
50% 50%
89%
274 274
16% 16%
11%
- Selling and Administrative Expenses 144 144
19% 19%
6%
- Research and Development Expense - -
-
-
131 131
13% 13%
5%
- Depreciation and Amortization 120 120
8% 8%
5%
EBIT (Operating Income) EBIT 11 11
44% 44%
0%
Net Profit -72 -72
21% 21%
-3%

In millions USD.

Don't miss a Thing! We will send you all news about Evolent Health Inc Class A directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Evolent Health Inc Class A Stock News

Positive
Seeking Alpha
14 days ago
Evolent Health has seen a significant 50% drop due to a Q3 earnings miss and high medical costs. Despite setbacks, Evolent secured record-breaking new business deals and anticipates over 15% annual revenue growth, driven by rate increases and strategic partnerships. EVH stock appears undervalued with a P/E ratio of 16.57, suggesting a potential contrarian buy opportunity given its long-term gro...
Neutral
Seeking Alpha
17 days ago
Evolent Health, Inc. (NYSE:EVH ) Q3 2024 Earnings Conference Call November 7, 2024 5:00 PM ET Participants Seth Blackley - Chief Executive Officer John Johnson - Chief Financial Officer Seth Frank - Vice President, Investor Relations Conference Call Participants Charles Rhyee - TD Cowen Jailendra Singh - Truist Securities Jeff Garro - Stephens Stephanie Davis - Barclays Ryan Daniels - William B...
Neutral
PRNewsWire
19 days ago
Revenue of $621.4 million, an increase of $110.4 million or 21.6%, from the three months ended September 30, 2023. Net loss attributable to common shareholders of Evolent Health, Inc. of $(31.2) million and a net loss margin of (5.0)%.
More Evolent Health Inc Class A News

Company Profile

Evolent Health, Inc. engages in the provision of health care delivery and payment services. It deals with population health management, health plan and third party administration, network performance and pharmacy benefit management, risk adjustment, analytics and performance improvement, and technology and electronic medical record integration. It operates through Services and True Health segments. The Services segment includes clinical and administrative solutions such as total cost of care management and specialty care management and comprehensive health plan administrative services. The True Health segment offers a physician-led health plan for employer-sponsored health coverage. The company was founded by Frank J. Williams, Seth B. Blackley, and Thomas Peterson III in August 2011 and is headquartered in Arlington, VA.

Head office United States
CEO Seth Blackley
Employees 4,700
Founded 2011
Website www.evolent.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today